07.02.2013 • News
Merck
05.11.2012 • News
Drugmakers Offer to Cap Greece's Medicines Bill
25.09.2012 • Topics • Technology
Stick to Your Strengths with Biosimilars
20.08.2012 • News
Changing Times
14.08.2012 • News
Merck KGaA Beats in Q2 on Rebif Drug
16.07.2012 • News
BASF to Take on Asia's Battery Chemicals Makers
06.06.2012 • News
Merck KGaA, Dr. Reddy's in Biosimilars Deal
15.04.2012 • News
Merck Serono Sets Up Biotech Incubator in Israel
05.04.2012 • News
Newron Agrees Parkinson's Drug Deal with Zambon
03.04.2012 • News
Lonza Appoints Richard Ridinger as New CEO
21.02.2012 • News
BASF Buys Merck's Electrolytes Business
31.10.2011 • News
Corning's Profit up but Doubts Mount on Demand
26.10.2011 • News
Peter Pollak on the World of Fine Chemicals
30.08.2011 • News
Merck Millipore Acquiring Amnis
08.06.2011 • News
Roche to Provide Tests for Merck Cancer Drugs
Evotec
SchüllerConsulting
Iktos AI
ISPE D/A/CH e.V.
Merck & Co
Thomson Reuters
CHEManager International c/o Wiley-VCH GmbH
Sartorius AG
Datamonitor Group
Together for Sustanability (TFS)
Codexis
Mack Brooks Exhibition Ltd – Part of RX
Merck KGaA
EvaluatePharma
Merck Chemicals Co. Ltd.
CHEManager c/o Wiley-VCH Verlag GmbH & Co. KGaA
Univers. St. Gallen
PP Consulting
KPMG
Millipore Corporation
ARC Advisory Group GmbH & Co KG
LANXESS Deutschland GmbH
Arthur D. Little
Frost & Sullivan